Till Bachmann, formerly Chief Operating Officer and Head of Biochip Research in the Division of Pathway Medicine (DPM) has been appointed Reader in Personalised Medicine in Infectious Diseases in recognition of his distinguished research record on molecular diagnostics of infectious diseases and antibiotic resistance
Till's appointment recognises the importance of his research in advanced detection techniques in the fight against antimicrobial resistance. I am pleased that he is able to pursue his research as a member of DPM
Professor Peter Ghazal
Head of Division of Pathway Medicine
Till has published extensively, is a named inventor on multiple patent applications, and he has led a number of large interdisciplinary diagnostic projects (e.g. ITI Techmedia Chronic Woundcare/Biosensing Platform Programme) leading to important translational impact. Till is a founding member of the European Diagnostics Cluster Association, and member of the Steering Group for the Biosensing Special Interest Group of the Electronics, Sensors, Photonics KTN.
I am delighted to have been offered a position as Reader in this important and emerging research area and to have been given the opportunity to take our research to the next level. This will enable us to generate a deeper understanding of the relationship between drugs, pathogens and their hosts. We will build on our expertise in biochip research to combine this knowledge with advanced companion diagnostic solutions targeting stratified approaches for infectious diseases.
Reader in Personalised Medicine in Infectious Diseases
This article was published on Sep 10, 2012